Chemical inhibitors of the proteasome have received substantial attention owing to the success of bortezomib in the treatment of multiple myeloma. A recent whole-cell screen identified the proteasome inhibitor argyrin A and suggests a new role for p27Kip-1 in regulating apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Goldberg, A.L. Biochem. Soc. Trans. 35, 12–17 (2007).
Adams, J. Cancer Cell 5, 417–421 (2004).
Richardson, P.G. et al. N. Engl. J. Med. 352, 2487–2498 (2005).
Chauhan, D. et al. Cancer Cell 8, 407–419 (2005).
Nickeleit, I. et al. Cancer Cell 14, 23–35 (2008).
Keats, J.J. et al. Cancer Cell 12, 131–144 (2007).
Nikiforov, M.A. et al. Proc. Natl. Acad. Sci. USA 104, 19488–19493 (2007).
Tan, T.T. et al. Cancer Cell 7, 227–238 (2005).
Sherr, C.J. & Roberts, J.M. Genes Dev. 9, 1149–1163 (1995).
Pandey, U.B. et al. Nature 447, 859–863 (2007).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McConkey, D. 20S ways to apoptosis. Nat Chem Biol 4, 528–529 (2008). https://doi.org/10.1038/nchembio0908-528
Issue Date:
DOI: https://doi.org/10.1038/nchembio0908-528
